1. Iosif CS, Bekassy Z, Rydhstrom H. Prevalence of urinary incontinence in middle-aged women. Int J Gynaecol Obstet. 1988; 26:255–9.
Article
2. Takahashi W, Yoshida M, Wada Y, Goto S, Inadome A, Yono M, et al. Effect of estrogen on nitric oxide-induced relaxation of the rabbit urethra. Eur J Pharmacol. 1997; 339:165–71.
Article
3. Dokita S, Morgan WR, Wheeler MA, Yoshida M, Latifpour J, Weiss RM. NG-nitro-L-arginine inhibits non-adrenergic, non-cholinergic relaxation in rabbit urethral smooth muscle. Life Sci. 1991; 48:2429–36.
Article
4. Hashimoto S, Kigoshi S, Muramatsu I. Nitric oxide-dependent and -independent neurogenic relaxation of isolated dog urethra. Eur J Pharmacol. 1993; 231:209–14.
Article
5. Leone AM, Wiklund NP, Hokfelt T, Brundin L, Moncada S. Release of nitric oxide by nerve stimulation in the human urogenital tract. Neuroreport. 1994; 5:733–6.
Article
6. Yallampalli C, Byam-Smith M, Nelson SO, Garfield RE. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology. 1994; 134:1971–4.
Article
7. Hextall A. Oestrogens and lower urinary tract function. Maturitas. 2000; 36:83–92.
Article
8. Ingelman-Sundberg A, Rosen J, Gustafsson SA, Carlstrom K. Cytosol estrogen receptors in the urogenital tissues in stress-incontinent women. Acta Obstet Gynecol Scand. 1981; 60:585–6.
Article
9. Hextall A, Cardozo L. The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12:258–61.
Article
10. Rand MJ, Li CG. Discrimination by the NO-trapping agent, carboxy-PTIO, between NO and the nitrergic transmitter but not between NO and EDRF. Br J Pharmacol. 1995; 116:1906–10.
Article
11. Bennett BC, Kruse MN, Roppolo JR, Flood HD, Fraser M, de Groat WC. Neural control of urethral outlet activity in vivo: role of nitric oxide. J Urol. 1995; 153:2004–9.
Article
12. Al-Hijji J, Batra S. Downregulation by estrogen of nitric oxide synthase activity in the female rabbit lower urinary tract. Urology. 1999; 53:637–41.
Article
13. Shapiro E. Effect of estrogens on the weight and muscarinic cholinergic receptor density of the rabbit bladder and urethra. J Urol. 1986; 135:1084–7.
Article
14. Larsson B, Andersson KE, Batra S, Mattiasson A, Sjogren C. Effects of estradiol on norepinephrine-induced contraction, alpha adrenoceptor number and norepinephrine content in the female rabbit urethra. J Pharmacol Exp Ther. 1984; 229:557–63.
15. Fantl JA, Wyman JF, Anderson RL, Matt DW, Bump RC. Postmenopausal urinary incontinence: comparison between non-estrogen-supplemented and estrogen-supplemented women. Obstet Gynecol. 1988; 71:823–8.
Article
16. Jackson S, Shepherd A, Brookes S, Abrams P. The effect of oestrogen supplementation on postmenopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol. 1999; 106:711–8.
Article
17. Beisland HO, Fossberg E, Moer A, Sander S. Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urol Int. 1984; 39:211–6.
18. Ho MH, Bhatia NN, Khorram O. Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract. Curr Opin Obstet Gynecol. 2004; 16:423–9.
Article
19. Chertin B, Rolle U, Solari V, Cascio S, Puri P. The role of nitric oxide in bladder urothelial injury after bladder outlet obstruction. BJU Int. 2004; 94:392–9.
Article
20. Aikawa K, Chichester P, Whitbeck C, Levin RM. Effect of nitric oxide synthase inhibition on changes induced by estradiol in bladders from ovariectomized rabbits. Urol Int. 2005; 75:133–8.
Article